← All indications
Dentin Sensitivity
Pain associated with exposed DENTIN surfaces of the teeth.
Drugs by status
Approved for this indication (2)
Phase 4 trials (10)
Phase 3 trials (11)
Phase 2 trials (4)
Phase 1 trials (6)
Other trials (22)
- metronidazole
- corticotropin
- bismuth
- cyanoacrylate
- vitis vinifera
- dipotassium oxalate monohydride
- hydroxyapatite silica
- miswak
- resin modified glass ionomer
- phosphoric acid
- enamelast
- stannous chloride
- tetracycline
- theobromine
- stannous fluoride
- acmella oleracea
- casein phosphopeptide amorphous calcium phosphate
- iqp-olp-101
- sodium monofluorphosphate
- strontium chloride
- butyl ester of methyl vinyl ether/maleic anhydride copolymer
- galla chinensis
Organizations
Organization Involved with Phase 4 Indications (6)
Organization Involved with Phase 3 Indications (10)
Organization Involved with Phase 2 Indications (4)
Organization Involved with Phase 1 Indications (2)
Organization Involved with Other Experimental Indications (13)
- InQpharm Group
- Tamil Nadu Dr.M.G.R.Medical University
- Federal University of Uberlandia
- University of Iowa
- Universidad del Desarrollo
- Fluminense Federal University
- Procter and Gamble
- Chad J Anderson DMD Inc
- Al Azhar University
- University of New England
- Johnson and Johnson
- Government of Saudi Arabia
- King Abdul-Aziz University